Ian Krop, MD, PhD
Professor of Internal Medicine (Medical Oncology)Cards
About
Research
Overview
Medical Research Interests
Clinical Care
Overview
Ian Krop, MD, PhD, is a professor of internal medicine, specializing in medical oncology, at Yale School of Medicine. He is a Yale Medicine specialist, with expertise in the management of breast cancer. Among his leadership roles at Yale Cancer Center, Dr. Krop serves as Associate Cancer Center Director for Clinical Research, Director of the Yale Cancer Center Clinical Trials Office, and Chief Clinical Research Officer.
Dr. Krop's research interests include the treatment of HER2-positive breast cancer through the investigation of various therapies, evaluation of genomic tools, and analysis of patient-reported outcomes. He participates in clinical trials that examine the role of neoadjuvant therapies in cancer treatment and ways to manage of spread of cancer to the brain. His work also examines patient-reported outcomes in breast cancer clinical trials and the correlation between the PIK3CA mutation and breast cancer outcomes.
Dr. Krop's research team has been awarded with grants from the National Cancer Institute, Susan G. Komen Breast Cancer Foundation, the Breast Cancer Research Foundation, and the American Association for Cancer Research. His work has significantly influenced patient care and medical education, leading to an improved understanding of resistance to HER2-directed therapies, the identification of potential tumor suppressors, and strategies to overcome residual disease in HER2-positive breast cancer.
News & Links
Media
The Evolution of Antibody-Drug Conjugates in Oncology: Have we found our “Magic Bullet”?
Yale Cancer Center Grand Rounds | January 28, 2-25
Presented by: Dr. Ian Krop
News
- January 15, 2025Source: OncLive
Commentary: Emerging HER2-Directed Agents May Address Resistance to SOC Regimens in Pretreated HER2+ Breast Cancer
- January 13, 2025
Dr. Ian Krop and Alyssa Gateman on Yale Cancer Answers: Increasing Access to Clinical Trials
- December 20, 2024Source: Medscape
Trial of ctDNA-directed Breast Cancer Therapy Fizzles Out
- December 17, 2024
Yale Cancer Center presents advances in breast cancer at the San Antonio Breast Cancer Symposium
Get In Touch
Contacts
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.